nystatin-a1 and Enterocolitis

nystatin-a1 has been researched along with Enterocolitis* in 1 studies

Reviews

1 review(s) available for nystatin-a1 and Enterocolitis

ArticleYear
[Intestinal candidiasis: modern therapeutic tactics].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2005, Issue:6

    Bowels candidiasis is an urgent problem not only for gastroenterology but also for other fields of medicine--gynecology, dentistry, phthisiology, surgery, etc. as this disease is directly related with the manifestations of systemic candidiasis in other organs. The diagnostics algorithm includes the detection of a filamentary form (pseudomyceliums) of micromycetes of the Candida genus in the morphological study of a tissue sampling of the bowels mucous coat. The drug of choice for the treatment of bowels candidiasis is Pimafucin (Natamycin) having a local action on the Candida fungi in the intestinal lumen in the absence of any systemic absorption of the drug or any side effects.

    Topics: Antifungal Agents; Candidiasis; Delayed-Action Preparations; Enterocolitis; Humans; Natamycin; Nystatin

2005